CompletedPhase 2ketamine

Ayahuasca and Esketamine for Major Depression

Sponsored by University of Sao Paulo

NCT ID
NCT07212946
Target Enrollment
22 participants
Start Date
2022-10-30
Est. Completion
2025-10-01

About This Study

Double-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.

Conditions Studied

Major Depression Severe

Interventions

  • •Ayahuasca
  • •Esketamine

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

\- Clinical diagnosis of depressive disorder

Exclusion Criteria:

\- Presence of psychiatric and other medical comorbidities

Study Locations (1)

Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo, Brazil

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Ayahuasca and Esketamine for Major Depression | Huxley